Transcript Genmab: CEO de Winkel forklarer betydning af J&J nej til videreførsel af Hexabody-CD38
10/3 19:29
Genmab A/S – Special Call March 10, 2025 at 12:00 pm EDT Operator Hello, and welcome to Genmab’s investor update. As a reminder, this conference call is being recorded. During this telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may differ […]...